trending Market Intelligence /marketintelligence/en/news-insights/trending/8r817SBkEjhfTe9Dfnafpw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Humana acquiring hospice pharmacy, benefit management provider Enclara

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Humana acquiring hospice pharmacy, benefit management provider Enclara

Humana Inc. agreed to acquire privately held hospice pharmacy and benefit management provider Enclara Healthcare from Consonance Capital Partners and Enclara management.

The transaction includes the acquisition of Enclara Pharmacia, GuidantRx and Avanti Health Care Services. Financial terms of the transaction were not disclosed, and certain assets are excluded.

The transaction is expected to have an immaterial impact to Humana's earnings in 2020. It is anticipated to close during the first half of 2020 and is subject to customary state and federal regulatory approvals as well as other customary closing conditions.

Enclara serves over 450 hospice providers and 97,000 hospice patients per day.

Centerview Partners LLC is serving as financial adviser to Humana. Crowell & Moring LLP is acting as legal adviser to Humana. Evercore Inc. is acting as financial adviser to Enclara and Consonance Capital. Latham & Watkins LLP is acting as legal adviser to Enclara and Consonance Capital.